1. AB0521 Safety, pharmacokinetics, and pharmacodynamics of single doses of a bispecific icosl and baff inhibitor, amg 570, in healthy subjects. (12th June 2018) Authors: Cheng, L.E.; Kankam, M.; Siebers, N.; Stoltz, R.; Abuqayyas, L.; Ertik, B.; Sullivan, B.A.; Zhou, L.; Mitragotri, D.; Parnes, J.R. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1418 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0084 SAFETY, PHARMACOKINETICS, PHARMACODYNAMICS, IMMUNOGENICITY, AND PRELIMINARY EFFICACY OF ROZIBAFUSP ALFA IN SUBJECTS WITH RHEUMATOID ARTHRITIS: INTERIM ANALYSIS OF A PHASE 1B RANDOMIZED, PLACEBO-CONTROLLED, MULTIPLE ASCENDING DOSE CLINICAL TRIAL. (2nd June 2020) Authors: Abuqayyas, L.; Cheng, L.; Mitragotri, D.; Smith, S.; Teixeira Dos Santos, M.; Zhou, Y.; Chindalore, V.; Cohen, S.; Kivitz, A.; Posch, M.; Sullivan, B.; Parnes, J. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗